Novosanis signs agreement with the Mexican distributor of medical devices Distribuidora GAP

You are here

GAP deal

Wijnegem, Belgium, July 20 2016: Novosanis, a medical device company based in Belgium, announced today a new distribution partnership with Distribuidora GAP, short for Distribuidora Química y Hospitalaria GAP. As part of this agreement, Distribuidora GAP will sell the Novosanis’ Colli-PeeTM, a medical device suited for collection of first void urine, in Mexico.

Distribuidora GAP is one of Mexico’s largest distributors dedicated to the promotion, sales and distribution of reagents, hospital materials and equipment for clinical laboratories.

"Distribuidora GAP has a strong expertise in the field of distribution of medical devices to labs and hospitals. This distribution partnership will strengthen the international position of Novosanis in Mexico." says Vanessa Vankerckhoven, CEO Novosanis.

Jesus Ortega Martínez, CEO at Distribuidora GAP: "We’re excited to distribute Colli-PeeTM to laboratories and hospitals in Mexico. Novosanis’ device allows easier and more patient-friendly detection of the Human papillomavirus that can lead to cervical cancer. This is still an important health problem to women living in rural and suburban regions of Mexico. Thanks to Colli-PeeTM we can have new ways to reach out to these remote groups of women. We believe this partnership will help us to fight HPV and save many women from cervical cancer."

About Novosanis

Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests, vaccination based actions and the overall patient’s comfort.

Novosanis is a medical device company active in the field of infectious diseases and oncology in the areas of prevention, detection and treatment.

Novosanis prospers in user-friendly and smart medical devices meeting all regulatory and quality requirements, solutions that can improve the accuracy of the diagnostic test while making the handling easier, more consistent and more comfortable for the person.

Currently Novosanis has two device platforms in portfolio: VAX-ID™, suited for accurate intradermal injections and Colli-Pee™, suited for standardized collection of first void urine. Colli-Pee™ is in commercial stage and is CE marked.


About Distribuidora Química y Hospitalaria

Distribuidora GAP is a young enterprising company committed to provide efficient, reliable and complete product solutions for everyday work in the clinical, molecular diagnostic and life science research laboratory disciplines.

The firm founded in 2004 has grown and developed through unremitting efforts into a patient-oriented company, providing comprehensive and innovative services of the highest quality under the following provisions:

  1. facilitate access to health,
  2. accelerate the delivery of patient outcome and
  3. anticipate changes to the health needs of the population.

For more information, please visit: